{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:54:13Z","timestamp":1790391253500,"version":"4.1.0"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/ http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The global liver community established a more precise criteria to characterize steatotic liver disease (SLD), specifically metabolic dysfunction\u2013associated steatotic liver disease (MASLD) and metabolic dysfunction\u2013associated and alcohol-associated liver disease (MetALD). We aimed to estimate the burden of SLD subtypes and unfavorable social determinants of health (SDOH) in US adults and whether clinical and social factors drive disparities across racial\/ethnic subgroups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We evaluated 4263 persons aged 20 years or older from the National Health and Nutrition Examination Survey 2017\u20132018. We estimated the weighted age-adjusted prevalence and severity of SLD, examined the prevalence of SDOH across SLD subtypes, and performed stepwise regression analysis to evaluate associations between race\/ethnicity and SLD, accounting for metabolic risks, alcohol use, and SDOH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Hispanic adults had the highest prevalence of MASLD (22.3%), MASLD-predominant MetALD (10.3%), alcohol-associated liver disease (ALD)-predominant MetALD (5.6%), and ALD (5.4%). Hispanic adults with MASLD had the highest prevalence of high-risk metabolic dysfunction\u2013associated steatohepatitis (18.0%) and advanced fibrosis (21.1%), whereas non-Hispanic (NH) White adults with MetALD had the highest prevalence of high-risk metabolic dysfunction\u2013associated steatohepatitis (19.3%), advanced fibrosis (19.5%), and cirrhosis (8.1%). Adults with ALD-predominant MetALD and ALD had an increased burden of unfavorable SDOH than those with MASLD, particularly food insecurity, limited health care access, and single living. In stepwise regression, the odds of SLD in Hispanic adults decreased after adjusting for metabolic risks (OR 1.40, 95% CI, 1.06\u20131.84) and alcohol use (OR 1.36, 95% CI, 1.01\u20131.82). Differences did not persist after adjusting for cumulative SDOH and nativity status (OR 1.22, 95% CI, 0.89\u20131.68).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>We found substantial disparities in the burden of unfavorable SDOH across SLD subtypes, particularly among those with ALD-predominant MetALD and ALD. Population-based approaches targeting SDOH may mitigate racial\/ethnic differences among US adults with SLD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/hc9.0000000000000324","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T12:01:58Z","timestamp":1701777718000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":60,"title":["Racial and ethnic differences and the role of unfavorable social determinants of health across steatotic liver disease subtypes in the United States"],"prefix":"10.1097","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7826-655X","authenticated-orcid":false,"given":"Pedro","family":"Ochoa-Allemant","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9604-5454","authenticated-orcid":false,"given":"Jorge A.","family":"Marrero","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4899-2160","authenticated-orcid":false,"given":"Marina","family":"Serper","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA"},{"name":"Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania, USA"},{"name":"Corporal Michael J. Crescenz VA Medical Center, US Department of Veterans Affairs, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,12]]},"reference":[{"key":"R1-20240826","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3350\/cmh.2022.0239","article-title":"Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach","volume":"28","author":"Le","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"R2-20240826","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"R3-20240826","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"R4-20240826","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"R5-20240826","article-title":"A multi-society Delphi consensus statement on new fatty liver disease nomenclature","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"R6-20240826","article-title":"Prevalence of steatotic liver disease and associated fibrosis in the United States: Results from NHANES 2017-March 2020","author":"Luo","year":"2023","journal-title":"J Hepatol"},{"key":"R7-20240826","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.cgh.2017.09.041","article-title":"Racial and ethnic disparities in nonalcoholic fatty liver disease prevalence, severity, and outcomes in the United States: A systematic review and meta-analysis","volume":"16","author":"Rich","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R8-20240826","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1002\/hep.32743","article-title":"Health disparities in chronic liver disease","volume":"77","author":"Kardashian","year":"2023","journal-title":"Hepatology"},{"key":"R9-20240826","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/MLR.0000000000001824","article-title":"Enhanced identification of hispanic ethnicity using clinical data: A study in the largest integrated United States Health Care System","volume":"61","author":"Ochoa-Allemant","year":"2023","journal-title":"Med Care"},{"key":"R10-20240826","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev-soc-073014-112305","article-title":"Is racism a fundamental cause of inequalities in health","volume":"41","author":"Phelan","year":"2015","journal-title":"Annu Rev Sociol"},{"key":"R11-20240826","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S2468-1253(21)00100-X","article-title":"Racial and ethnic disparities in non-alcoholic fatty liver disease in the USA","volume":"6","author":"Rich","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R12-20240826","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jhep.2023.01.026","article-title":"Healthcare and socioeconomic costs of NAFLD: A global framework to navigate the uncertainties","volume":"79","author":"Allen","year":"2023","journal-title":"J Hepatol"},{"key":"R13-20240826","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/hep4.1831","article-title":"Community socioeconomic deprivation predicts nonalcoholic steatohepatitis","volume":"6","author":"Giammarino","year":"2022","journal-title":"Hepatol Commun"},{"key":"R14-20240826","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1016\/j.cgh.2021.11.029","article-title":"Food insecurity is associated with mortality among US adults with nonalcoholic fatty liver disease and advanced fibrosis","volume":"20","author":"Kardashian","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R15-20240826","first-page":"1","article-title":"National Health and Nutrition Examination Survey, 2015-2018: Sample design and estimation procedures","volume":"184","author":"Chen","year":"2020","journal-title":"Vital Health Stat 2"},{"key":"R18-20240826","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1001\/jamaophthalmol.2023.0723","article-title":"Association between social determinants of health and examination-based vision loss vs self-reported vision measures","volume":"141","author":"Alfaro Hudak","year":"2023","journal-title":"JAMA Ophthalmol"},{"key":"R19-20240826","doi-asserted-by":"crossref","first-page":"e026797","DOI":"10.1161\/JAHA.122.026797","article-title":"Social Determinants of cardiovascular health in US adolescents: National Health and Nutrition Examination Surveys 1999 to 2014","volume":"11","author":"Connolly","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"R20-20240826","doi-asserted-by":"crossref","first-page":"e422","DOI":"10.1016\/S2468-2667(23)00081-6","article-title":"Social determinants of health and premature death among adults in the USA from 1999 to 2018: A national cohort study","volume":"8","author":"Bundy","year":"2023","journal-title":"Lancet Public Health"},{"key":"R22-20240826","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"R23-20240826","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: An American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"R24-20240826","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S2468-1253(19)30383-8","article-title":"FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: A prospective derivation and global validation study","volume":"5","author":"Newsome","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R25-20240826","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"R26-20240826","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"R27-20240826","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/ajg.2016.453","article-title":"Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis","volume":"112","author":"McPherson","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"R28-20240826","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cgh.2018.04.043","article-title":"Vibration-controlled transient elastography to assess fibrosis and steatosis in patients with nonalcoholic fatty liver disease","volume":"17","author":"Siddiqui","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R30-20240826","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1001\/jama.2019.2276","article-title":"Prevalence of alcoholic fatty liver disease among adults in the United States, 2001-2016","volume":"321","author":"Wong","year":"2019","journal-title":"JAMA"},{"key":"R31-20240826","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ajg.2017.469","article-title":"ACG Clinical Guideline: Alcoholic liver disease","volume":"113","author":"Singal","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"R32-20240826","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cgh.2021.12.029","article-title":"Prevalence of high-risk nonalcoholic steatohepatitis (NASH) in the United States: Results From NHANES 2017-2018","volume":"21","author":"Vilar-Gomez","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R33-20240826","first-page":"1","article-title":"Age adjustment using the 2000 projected US population","volume":"20","author":"Klein","year":"2001","journal-title":"Healthy People 2000 Stat Notes"},{"key":"R34-20240826","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1016\/j.cgh.2019.07.060","article-title":"Contemporary epidemiology of chronic liver disease and cirrhosis","volume":"18","author":"Moon","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R35-20240826","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.cgh.2014.08.037","article-title":"Prevalence of suspected nonalcoholic fatty liver disease in Hispanic\/Latino individuals differs by heritage","volume":"13","author":"Kallwitz","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R36-20240826","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.3748\/wjg.v20.i17.4987","article-title":"NAFLD prevalence differs among hispanic subgroups: The Multi-Ethnic Study of Atherosclerosis","volume":"20","author":"Fleischman","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R37-20240826","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"key":"R38-20240826","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/hep.31608","article-title":"Hepatic fibrosis associates with multiple cardiometabolic disease risk factors: The Framingham Heart Study","volume":"73","author":"Long","year":"2021","journal-title":"Hepatology"},{"key":"R39-20240826","doi-asserted-by":"crossref","first-page":"k2817","DOI":"10.1136\/bmj.k2817","article-title":"Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: Observational study","volume":"362","author":"Tapper","year":"2018","journal-title":"BMJ"},{"key":"R40-20240826","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/apt.16461","article-title":"Alcohol-associated liver disease in the United States is associated with severe forms of disease among young, females and Hispanics","volume":"54","author":"Singal","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"R41-20240826","doi-asserted-by":"crossref","first-page":"100172","DOI":"10.1016\/j.lanepe.2021.100172","article-title":"Socioeconomic inequalities in the incidence of alcohol-related liver disease: A nationwide Danish study","volume":"8","author":"Askgaard","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"R42-20240826","doi-asserted-by":"crossref","first-page":"e2022942","DOI":"10.1001\/jamanetworkopen.2020.22942","article-title":"Changes in adult alcohol use and consequences during the COVID-19 pandemic in the US","volume":"3","author":"Pollard","year":"2020","journal-title":"JAMA Netw Open"},{"key":"R43-20240826","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1001\/jama.2022.4308","article-title":"Alcohol-Related Deaths During the COVID-19 Pandemic","volume":"327","author":"White","year":"2022","journal-title":"JAMA"},{"key":"R44-20240826","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1056\/NEJMe1514957","article-title":"The obesity epidemic--Understanding the disease and the treatment","volume":"374","author":"Apovian","year":"2016","journal-title":"N Engl J Med"},{"key":"R45-20240826","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11892-018-1004-6","article-title":"Sugar-sweetened beverage, obesity, and type 2 diabetes in children and adolescents: Policies, taxation, and programs","volume":"18","author":"Yoshida","year":"2018","journal-title":"Curr Diab Rep"},{"key":"R46-20240826","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1053\/j.gastro.2021.03.031","article-title":"Alcohol policies and alcohol-related liver disease mortality","volume":"161","author":"Parikh","year":"2021","journal-title":"Gastroenterology"},{"key":"R47-20240826","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/S0140-6736(23)00497-X","article-title":"Evaluating the impact of alcohol minimum unit pricing on deaths and hospitalisations in Scotland: A controlled interrupted time series study","volume":"401","author":"Wyper","year":"2023","journal-title":"Lancet"}],"container-title":["Hepatology Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HC9.0000000000000324","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T10:24:10Z","timestamp":1724667850000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/HC9.0000000000000324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":43,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/hc9.0000000000000324","relation":{},"ISSN":["2471-254X"],"issn-type":[{"value":"2471-254X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"2023-09-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}